| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 171.61B | 158.99B | 119.46B | 86.11B | 71.15B | 50.72B |
| Gross Profit | 36.51B | 35.25B | 29.59B | 22.54B | 18.42B | 13.84B |
| EBITDA | 8.04B | 9.28B | 9.03B | 6.66B | 4.40B | 674.61M |
| Net Income | 3.72B | 4.78B | 5.03B | 3.71B | 2.26B | -595.59M |
Balance Sheet | ||||||
| Total Assets | 98.58B | 88.63B | 64.04B | 46.75B | 39.67B | 37.40B |
| Cash, Cash Equivalents and Short-Term Investments | 19.94B | 15.54B | 18.09B | 12.28B | 10.74B | 11.98B |
| Total Debt | 58.18B | 47.40B | 27.73B | 16.50B | 13.52B | 14.75B |
| Total Liabilities | 66.07B | 55.43B | 35.27B | 22.51B | 18.97B | 18.96B |
| Stockholders Equity | 32.11B | 32.77B | 28.41B | 23.93B | 20.44B | 18.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.86B | -3.27B | -105.68M | 506.18M | 2.92B |
| Operating Cash Flow | 0.00 | -5.18B | -548.05M | 1.54B | 1.13B | 4.38B |
| Investing Cash Flow | 0.00 | -6.71B | -3.22B | -1.95B | -529.30M | -1.22B |
| Financing Cash Flow | 0.00 | 11.91B | 9.43B | 1.85B | -1.90B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥54.02B | 3.13 | ― | 3.69% | 36.03% | -27.99% | |
70 Outperform | ¥29.40B | 6.21 | ― | 3.99% | 3.72% | -27.94% | |
67 Neutral | ¥34.30B | 18.57 | 5.90% | 3.07% | 3.04% | 44.65% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥30.34B | 7.18 | ― | 4.20% | 6.26% | -4.41% | |
60 Neutral | ¥70.34B | 9.58 | ― | 5.71% | 8.07% | 12.06% | |
56 Neutral | ¥33.50B | 7.38 | ― | 6.11% | 81.19% | 250.41% |